Free Trial

Millennium Management LLC Sells 276,420 Shares of Maximus, Inc. (NYSE:MMS)

Maximus logo with Business Services background

Millennium Management LLC cut its stake in Maximus, Inc. (NYSE:MMS - Free Report) by 45.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 336,679 shares of the health services provider's stock after selling 276,420 shares during the quarter. Millennium Management LLC owned 0.59% of Maximus worth $25,133,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in MMS. UMB Bank n.a. grew its position in Maximus by 79.8% during the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock valued at $27,000 after buying an additional 158 shares during the period. V Square Quantitative Management LLC grew its position in Maximus by 65.9% during the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock valued at $34,000 after buying an additional 180 shares during the period. Hillsdale Investment Management Inc. grew its position in Maximus by 0.4% during the fourth quarter. Hillsdale Investment Management Inc. now owns 52,400 shares of the health services provider's stock valued at $3,912,000 after buying an additional 230 shares during the period. Bridge City Capital LLC grew its position in Maximus by 0.9% during the fourth quarter. Bridge City Capital LLC now owns 28,503 shares of the health services provider's stock valued at $2,128,000 after buying an additional 254 shares during the period. Finally, Inspire Advisors LLC grew its position in Maximus by 3.1% during the fourth quarter. Inspire Advisors LLC now owns 8,650 shares of the health services provider's stock valued at $646,000 after buying an additional 258 shares during the period. 97.21% of the stock is currently owned by institutional investors.

Insider Transactions at Maximus

In related news, Director Jan Madsen sold 2,439 shares of the business's stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the sale, the director now owns 18,097 shares in the company, valued at approximately $1,225,347.87. The trade was a 11.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Ilene R. Baylinson sold 14,500 shares of the business's stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the sale, the insider now owns 2,512 shares in the company, valued at $171,167.68. This represents a 85.23% decrease in their position. The disclosure for this sale can be found here. Insiders own 1.60% of the company's stock.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered shares of Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th.

Check Out Our Latest Analysis on Maximus

Maximus Price Performance

Shares of NYSE:MMS opened at $75.16 on Tuesday. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.97. The company has a market capitalization of $4.24 billion, a P/E ratio of 16.16 and a beta of 0.61. The firm's 50 day simple moving average is $68.88 and its two-hundred day simple moving average is $72.47.

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, beating the consensus estimate of $1.37 by $0.64. Maximus had a net margin of 5.28% and a return on equity of 21.95%. The business had revenue of $1.36 billion for the quarter, compared to the consensus estimate of $1.29 billion. During the same quarter in the previous year, the firm earned $1.57 earnings per share. The company's revenue for the quarter was up 1.0% on a year-over-year basis. Research analysts expect that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.60%. The ex-dividend date of this dividend is Thursday, May 15th. Maximus's dividend payout ratio (DPR) is presently 23.86%.

About Maximus

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Recommended Stories

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS - Free Report).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Maximus Right Now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines